AVITA Medical Inc (NASDAQ:RCEL) has been awarded a group purchasing agreement with Premier Inc (NASDAQ:PINC) The new agreement allows Premier members, at their…
AVITA Medical, Inc. (NASDAQ:RCEL, ASX: AVH)), a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs,
AVITA Medical (NASDAQ:RCEL) reported its Q2 earnings results on Monday, February 28, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.